Immuno-Oncology & Biomarker Summit 2026
This two-day event is dedicated to advancing innovation in cancer immunotherapy and biomarker science. The agenda will cover the latest in antibody-drug conjugates (ADCs), bispecific antibodies, cellular therapies, immune checkpoint inhibitors, and novel combination strategies, along with insights into pre-clinical research, translational approaches, and the evolution of personalized immunotherapy. A strong emphasis will be placed on biomarker discovery, […]